<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Remedy-Kombucha on Bioecon</title><link>https://en.bioecon.ru/companies/remedy-kombucha/</link><description>Recent content in Remedy-Kombucha on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 07 Jul 2026 08:41:26 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/remedy-kombucha/index.xml" rel="self" type="application/rss+xml"/><item><title>Bio-nutraceutical drinks and functional beverages</title><link>https://en.bioecon.ru/technology/bio-nutraceutical-drinks-functional-beverages/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/bio-nutraceutical-drinks-functional-beverages/</guid><description>Prebiotic sodas, kombucha and cold-pressed wellness shots have moved from health-food-store niche to mainstream beverage aisle — PepsiCo&amp;rsquo;s nearly $2 billion acquisition of Poppi is the clearest signal that gut-health functional beverages are now core, not adjacent, to incumbent beverage strategy.</description></item></channel></rss>